Canada is a global leader in quantum science. Waterloo scientists are harnessing the potential of this disruptive science to create secure quantum communication and expand quantum computing with new funding from the NSERC Quantum Alliance grants.
In an age of misinformation, knowledge translation is an increasingly important way to communicate research to the audiences who need it.
Dr. Scott Taylor has been awarded the Bernard Belleau Award from the Chemical Institute of Canada for his numerous and important contributions to medicinal chemistry. Taylor is a world leader in the study of an important class of antibacterial drugs known as the calcium-dependent lipopeptide antibiotics (CDAs).
With the quantum age on the horizon, scientists are working to develop quantum computers that will have a processing speed exponentially faster than today’s most advanced supercomputer. Building a useful quantum computer is one of the great engineering challenges of our time. In all implementations, qubits that are reliable, stable, and scalable are essential in this endeavour.
Energy is present everywhere in the universe, from the tiniest particles to the vastness of space. According to quantum mechanics, vacuum states like outer space are not actually empty, because when observed at microscopic scales, there are spontaneous energy fluctuations.
Water has many unique properties. An interdisciplinary team of Waterloo scientists has discovered a one-dimensional chain of water molecules could produce a quantum phase transition. This breakthrough is a key development for future water-based quantum devices.
Dr. Scott Taylor has been awarded the Bernard Belleau Award from the Chemical Insitute of Canada for his contributions to medicinal chemistry.
The University of Waterloo was awarded nearly $10 million in federal funding yesterday for a major initiative to rebuild Canada's pandemic-battered aeronautics sector and position it for a more sustainable future.
Waterloo School of Pharmacy researchers have found that in patients with type-2 diabetes experiencing severe hypoglycaemic events, where blood glucose levels fall below normal to potentially dangerous levels leading to either a hospitalization or physician visit, is consistently linked with the development of dementia.